Firms

Epidarex Capital

A transatlantic venture firm that creates and finances early-stage therapeutics and medical-device companies from research in the UK and United States. It works with scientists and university spinouts across neurological, oncology, cardiometabolic and autoimmune conditions.

Founded: —
Type: Venture capital

Funds1

Epidarex Capital IV, LP2026-01-272026-01-27$145M
First close securing more than USD 145 million in commitments to build early-stage therapeutics and medical-device businesses in the UK and US, including companies addressing neurological disease. Plans up to 15 investments. Amount records the published USD 145 million threshold, rather than a final fund close.

Team

A. Sinclair Dunlop Epidarex Capital, Managing Partner	—— – —
Elizabeth Roper Epidarex Capital, Managing Partner	—— – —
Henning Steinhagen Epidarex Capital, Venture Partner	—— – —
Kyparissia Sirinakis Epidarex Capital, Founding Partner	—— – —
Lori Krim Gough Epidarex Capital, Partner	—— – —
Mary Canning Epidarex Capital, Partner	—— – —
Matthew Miessau Epidarex Capital, Principal	—— – —
Melissa Lezameta Epidarex Capital, Senior Associate	—— – —
Peter Finan Epidarex Capital, Managing Partner	—— – —
Victor Pong Epidarex Capital, Associate	—— – —

Operations and support

Alicia MacLeodExecutive Assistant

Andrew PrinceStaff Accountant

Anthony VoverisChief Financial Officer

Bridget HarrisDirector of Operations

Clare GaffneyOperations and Executive Assistant

Jeani DelagardelleAdvisory Board Member

Paul SekhriAdvisory Board Member

Sara McGeachyInvestor Relations Analyst

William BurnsAdvisory Board Member

William SellersAdvisory Board Member

Co-investing

Dolby Family Ventures

Libra Therapeutics$— · Unknown date

Morningside Ventures

Apellis Pharmaceuticals$— · Unknown date

Vensana Capital

Nyra Medical$— · Unknown date

Versant Ventures

Enterprise Therapeutics$— · Unknown date

$46M2026-08-05	Mironid	Epidarex Capital
$—Unknown date	SIRAKOSS	Epidarex Capital
$—Unknown date	Kynos Therapeutics	Epidarex Capital
$—Unknown date	Harpoon Medical	Epidarex Capital
$—Unknown date	Edinburgh Molecular Imaging	Epidarex Capital
$—Unknown date	Confluence Life Sciences	Epidarex Capital
$—Unknown date	Caldan Therapeutics	Epidarex Capital
$—Unknown date	Apellis Pharmaceuticals	Epidarex Capital, Morningside Ventures
$—Unknown date	AdoRx Therapeutics	Epidarex Capital
$—Unknown date	Slate Bio	Epidarex Capital
$—Unknown date	Ryme Medical	Epidarex Capital
$—Unknown date	Kodikaz Therapeutic Solutions	Epidarex Capital
$—Unknown date	Dunad Therapeutics	Epidarex Capital
$—Unknown date	Lunac Therapeutics	Epidarex Capital
$—Unknown date	Enterprise Therapeutics	Epidarex Capital, Versant Ventures
$—Unknown date	Nyra Medical	Epidarex Capital, Vensana Capital
$—Unknown date	Curve Therapeutics	Epidarex Capital
$—Unknown date	Topas Therapeutics	Epidarex Capital
$—Unknown date	Theolytics	Epidarex Capital
$—Unknown date	Macomics	Epidarex Capital
$—Unknown date	Leucid Bio	Epidarex Capital
$—Unknown date	Epsilogen	Epidarex Capital
$—Unknown date	Clyde Biosciences	Epidarex Capital
$—Unknown date	Libra Therapeutics	Epidarex Capital, Dolby Family Ventures
$—Unknown date	Rezera	Epidarex Capital
$—Unknown date	RapidPulse	Epidarex Capital
$—Unknown date	Lario Therapeutics	Epidarex Capital
$—Unknown date	Harness Therapeutics	Epidarex Capital

Funds1

Team

Operations and support

Co-investing

Investments